Article | Repurposing Drugs for Respiratory Delivery

Respiratory delivery of drugs has already moved beyond the traditional Asthma/COPD space with new therapeutics including antibiotics and anti-viral treatments, pulmonary hypertension, diabetes management, narcotic overdose, and other CNS and mental health treatments at various stages of development and marketing.
 
Repurposing existing active pharmaceutical ingredients for respiratory delivery is a growing trend in the industry, potentially offering reduced costs and time compared to new chemical entity (NCE) / new biologic entity (NBE) development and there are obvious benefits in lifecycle management of existing marketed products.
 
Find out more about the advantages, disadvantages and challenges associated with repurposing existing active pharmaceutical ingredients for respiratory delivery with our article now: